Asuragen Competitors and Similar CompaniesClear all

Asuragen's competitors and similar companies include Personalis, MNG Laboratories, Ambry Genetics, Myriad Genetics and Empire Genomics.

	Asuragen Asuragen is a molecular diagnostic product company.	Personalis Personalis is a biotechnology company that specializes in cancer genomics.	MNG Laboratories MNG Laboratories (also known as Medical Neurogenetics) is a company engaged in clinical diagnostic.	Ambry Genetics Ambry Genetics is a company that provides genetic testing solutions.	Myriad Genetics Myriad Genetics is a company that develops and offers genetic tests.	Empire Genomics Empire Genomics is a company that designs, manufactures, and distributes clinical and custom labeled molecular probes for biomarker research and diagnostics.
Founding Date	Founding Date 2006	Founding Date 2011	Founding Date 2001	Founding Date 1999	Founding Date 1991	Founding Date 2006
Type	Type Subsidiary	Type Public	Type Subsidiary	Type Subsidiary	Type Public	Type Private
Tags	Tags Healthcare biotech genetics medical diagnostics oncology	Tags Technology biotech genetics platform	Tags Healthcare biotech clinical research genetics	Tags Healthcare biotech genetics medical diagnostics	Tags Healthcare genetics medical diagnostics medical imaging oncology	Tags Healthcare biotech clinical research life sciences medical diagnostics
Locations	Locations Austin, US HQ	Locations Fremont, US HQ West Wickham, GB	Locations Atlanta, US HQ	Locations Aliso Viejo, US HQ Aliso Viejo, US	Locations Salt Lake City, US HQ Paris, FR Munich, DE Tokyo, JP Amsterdam, NL Zürich, CH	Locations Buffalo, US HQ Buffalo, US
Employees	Employees 1282% increase	Employees 22344% decrease	Employees 225% increase	Employees 9094% increase	Employees 2,700	Employees 19
Valuation ($)	Valuation ($) N/A	Valuation ($) 340.9 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 2 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $69.6m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $824.5m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $53.9m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods $247.9m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $15.8m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit $576.6m (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income ($81.3m) (FY, 2025)	Net income N/A	Net income N/A	Net income ($365.9m) (FY, 2025)	Net income N/A
Operating ⚠
Trademarks (US)	Trademarks (US) N/A	Trademarks (US) N/A	Trademarks (US) 6 (Nov, 2022)	Trademarks (US) 65 (Aug, 2022)	Trademarks (US) N/A	Trademarks (US) N/A
Funding
Total funding raised	Total funding raised $ 80m	Total funding raised $ 75m	Total funding raised $ 47.2k	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A